More than a decade after vaccination, women who had received a single dose of the HPV vaccine continued to be protected against infection with the two cancer-causing HPV types targeted by the vaccine, an NCI-funded clinical trial shows.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/3cdQinn
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/3cdQinn